Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 9 | 13 | +5,43 % | ||
| TRAVERE THERAPEUTICS | 9 | 11 | -32,65 % | ||
| APELLIS PHARMACEUTICALS | 7 | 4 | -5,00 % | ||
| ILLUMINA | 6 | - | +0,38 % | ||
| REVOLUTION MEDICINES | 4 | 5 | +4,00 % | ||
| ERASCA | 4 | 2 | +9,15 % | ||
| TEMPUS AI | 4 | 1 | -3,36 % | ||
| VERICEL | 4 | - | -4,29 % | ||
| AMGEN | 3 | 27 | +0,11 % | ||
| BIOMARIN PHARMACEUTICAL | 3 | 12 | -3,88 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:34 | ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook | 2 | Zacks | ||
| 18:29 | AstraZeneca to acquire Modella AI to speed oncology drug research | 4 | Channel NewsAsia | ||
| 17:06 | Guggenheim reiterates Buy rating on Abivax stock amid M&A speculation | 9 | Investing.com | ||
| 17:02 | Block & Leviton LLP: Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation | 185 | Newsfile | Boston, Massachusetts--(Newsfile Corp. - January 13, 2026) - Block & Leviton is investigating Aquestive Therapeutics, Inc. (NASDAQ: AQST) for potential securities law violations. Investors who have... ► Artikel lesen | |
| 16:54 | Illumina Introduces Illumina Billion Cell Atlas To Accelerate AI Drug Discovery | 160 | AFX News | LONDON (dpa-AFX) - Illumina, Inc. (ILMN), Tuesday introduced Illumina Billion Cell Atlas, a genome-wide genetic perturbation dataset, which is built to accelerate drug discovery through AI across... ► Artikel lesen | |
| 16:45 | Orchestra BioMed to pick up $21M through Haemonetics' acquisition of Vivasure | 2 | MassDevice | ||
| 16:42 | Truist Securities lowers Autolus Therapeutics stock price target on soft guidance | 6 | Investing.com | ||
| 16:38 | Eilmeldung am Abend: BIONTECH SE ADR zündet den Turbo! | 93 | Maximilian Berger | ||
| 16:31 | EILMELDUNG: Biontech startet durch - beginnt jetzt die Rallye? - jetzt handeln! | Hebelschein-Spekulant | |||
| 16:26 | JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study | 4 | FierceBiotech | ||
| 16:22 | Goldman Sachs bekräftigt "Buy"-Rating für Revolution Medicines mit Kursziel von 73 US-Dollar | 4 | Investing.com Deutsch | ||
| 16:18 | Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26 | 1 | Investing.com | ||
| 16:15 | Travere Therapeutics Hammered On A Potential, Surprise Delay For Filspari | 8 | Investor's Business Daily | ||
| 16:06 | Major Decision: Darin Lippoldt Exercises Options, Realizing $320K At Neurocrine Biosciences | 2 | Benzinga.com | ||
| 16:06 | Illumina Preliminary Q4, Annual Results Beat Analysts' View | 172 | AFX News | SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), a biotechnology company, on Tuesday reported preliminary results for the fourth quarter and fiscal 2025 above analysts' expectations.For the fourth... ► Artikel lesen | |
| 15:58 | BMO Capital bestätigt "Outperform"-Rating für Gilead Sciences | 4 | Investing.com Deutsch | ||
| 15:58 | Travere-Aktie stürzt ab: FDA fordert weitere Daten zu Nierenmedikament | 4 | Investing.com Deutsch | ||
| 15:54 | Illumina launches billion cell atlas to boost AI-driven drug discovery | 3 | Investing.com | ||
| 15:54 | Gilead Sciences stock rating reiterated at Outperform by BMO Capital | 4 | Investing.com | ||
| 15:54 | Oppenheimer reiterates Outperform rating on Lexeo Therapeutics stock | 4 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .